SCHEMBL3557435

SCHEMBL3557435

COc1ccc2c(c1)c(OCCN(C)C)c(C)n2C(C)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HTR6 P50406 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2D6 P10635 2/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP2C19 P33261 1/20 0.43
PTGS2 P35354 1/20 0.43
AKR1C3 P42330 2/20 0.42
MTNR1A P48039 1/20 0.42
AKR1C2 P52895 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
LMNA P02545 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
NFKB1 P19838 1/20 0.42
HIF1A Q16665 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6817298 0.86 LMNA (0.61) MEN1KMT2AHTR6CYP1A2CYP2D6
SCHEMBL3553237 0.86 KDM4E (0.44) HPGDMEN1KMT2ACYP1A2ALDH1A1
SCHEMBL3567569 0.85 ALDH1A1 (0.43) HPGDMEN1KMT2ACYP1A2CYP2D6
SCHEMBL6920070 0.84 MEN1 (0.44) MEN1KMT2ACYP1A2CYP2D6ALDH1A1
SCHEMBL3557475 0.84 HTR6 (0.45) MEN1KMT2AHTR6CYP1A2CYP2D6
SCHEMBL6823922 0.82 CNR1 (0.47) HPGDMEN1KMT2AHTR6CYP1A2
SCHEMBL3557135 0.82 POLB (0.47) HPGDMEN1KMT2AALDH1A1MAPT
SCHEMBL3566087 0.78 HTR6 (0.60) HTR6
SCHEMBL3560763 0.78 HTR6 (0.72) HTR6
SCHEMBL3560116 0.78 KDM4E (0.43) HPGDCYP1A2ALDH1A1CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed
EP-1567492-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES Suven Life Sciences Limited (IN) 2005-08-31 EP disclosed
WO-2004048328-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LIMITED (IN) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT HPGD 1804/4885MEN1 1490/4885KMT2A 1753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.